Zhen‐Yu He

机构：Sun Yat-sen University, Hunan University, Wuhan University of Technology, Sun Yat-sen University Cancer Center · ORCID：0000-0003-1402-8963

发表论文 215 篇 · 总被引 5045 次 · h-index 35

代表论文

• Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial (2024 · The Lancet · 被引 192)
• Prognostic significance of the skeletal muscle index and systemic inflammatory index in patients with lymph node-positive breast cancer after radical mastectomy (2022 · BMC Cancer · 被引 24)
• PD-1 blockade with sintilimab plus induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) versus IC-CCRT in locoregionally-advanced nasopharyngeal carcinoma (LANPC): A multicenter, phase 3, randomized controlled trial (CONTINUUM). (2023 · Journal of Clinical Oncology · 被引 19)
• Novel Insight into the Etiology of Haff Disease by Mapping the N-Glycome with Orthogonal Mass Spectrometry (2022 · Engineering · 被引 15)
• Impacts of Interactions between Grid-forming and Grid-following Converters on Stability of Hybrid System Connected to Weak Grid (2024 · 被引 10)
• Impact of the 21-gene expression assay on treatment decisions and clinical outcomes in breast cancer with one to three positive lymph nodes (2023 · Frontiers in Endocrinology · 被引 9)